No coin nor oath required. For personal study only.
The aim was to evaluate in a prospective, randomized setting if the 2-stage implant, compared to a 1-staged implant, leads to a superior subjective or objective outcome of sacral nerve stimulation after implantation of the pulse generator in patients with overactive bladder symptoms.
From October 2000 till January 2002 we implanted a sacral (S3) foramen lead (model 3080) and a pulse generator (Interstim) in 22 women with overactive bladder symptoms. All patients were first evaluated for treatment by a 4-7 days (3days diary) percutaneous nerve evaluation test (PNE) and were randomized in a 1stage or a 2-stage (1) implant if a more then 50% improvement in incontinence (pad weight -urge incontinence) or functional bladder capacity (urgency/frequency) is seen compared to baseline. Patients were randomized according to their symptoms (urgency/frequency or urge incontinence) and age. The 2-stage implant is evaluated during 3-5 weeks (3 days diary/week). A follow-up visit was done at 3 and 12 months after implantation of the pulse generator. Subjective improvement was evaluated with a visual analogue scale (VAS) for general well-being and for well-being related to bladder symptoms. Objective improvement was
📜 SIMILAR VOLUMES
## Aims of Study Urinary incontinence is a common condition that adversely affects quality of life [1]. Current medical therapy is associated with significant adverse effects which are known to affect compliance [2]. Desmopressin, a synthetic analogue of ADH is effective in the management of noctu